CompletedPhase 4ACTRN12612000001897

Intraoperative magnesium infusion as an adjuvant to bilateral single-injection thoracic paravertebral block for laparoscopic cholecystectomy

the use of magnesium sulfate infusion as an adjuvant to thoracic paravertebral block for laparoscopic cholecystectomy decreases postoperative fentanyl consumption. a randomized, double blind,controlled trial.


Sponsor

dr. waleed abdelmageed

Enrollment

59 participants

Start Date

Apr 3, 2010

Study Type

Interventional

Conditions

Summary

Background: Magnesium has antinociceptive effects. This study was designed to examine whether intraoperative administration of i.v magnesium with bilateral thoracic paravertebral block (PVB) enhances postoperative analgesia while reducing opioid consumption and opioid-related side effects. Methods: In this prospective randomized, double-blinded, controlled study, 59 patients undergoing laparoscopic cholecystectomy were given bilateral single injection PVB at the level of T5. Before induction of general anaesthesia, patients were assigned to two groups. Group M (magnesium group) received a loading dose of magnesium sulphate 30 mg per kg in 100 ml of normal saline over 10 min followed by an infusion of 10 mg per kgper h till the end of surgery. Control group (group C) received the same volume of normal saline as a loading dose followed by a continuous infusion. In both groups, postoperative pain was initially controlled by i.v. fentanyl titration and then fentanyl PCA. Cumulative PCA fentanyl consumption, pain intensities, sedation scores, cardiovascular and respiratory variables and opioid-related adverse effects were recorded for 36 h after operation.


Eligibility

Sex: Both males and femalesMin Age: 20 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

This trial investigates whether adding intravenous magnesium to a nerve block improves pain relief after laparoscopic gallbladder removal surgery in adults aged 20-60. Participants must be relatively healthy (ASA class I-II). Those with heart disease, kidney or liver problems, neuromuscular disease, obesity (BMI over 35), blood clotting disorders, or allergy to magnesium or opioids are excluded.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

patients undergoing laparoscopic cholecystectomy were given bilateral single injection thoracic paravertebral block at the level of T5 with 25ml of 0.25% bupivacaine. Before induction of general anaes

patients undergoing laparoscopic cholecystectomy were given bilateral single injection thoracic paravertebral block at the level of T5 with 25ml of 0.25% bupivacaine. Before induction of general anaesthesia, Group M (magnesium group) received a loading dose of magnesium sulphate 30 mg per kg in 100 ml of normal saline over 10 min followed by an infusion of 10 mg per kg per h till the end of surgery. Control group (group C) received the same volume of normal saline as a loading dose followed by a continuous infusion.


Locations(1)

eastern province, Saudi Arabia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000001897